Company news
31.08.10
Lab21 launches new commercial companion diagnostic service for HIV tropism in UK →
26.08.10
Lab21 licences pharmacogenetic IP for CES-1 from MUSC →
01.06.10
Lab21 achieves first product registration in China →
24.05.10
Lab21 and Virco partner to offer UK-based HIV-1 genotyping services →
18.12.09
Lab21 acquires US nanotechnology company and establishes Lab21 Inc. in South Carolina →
26.11.09
Lab21 acquires personalised medicine diagnostic services business →
Investor relations
Introduction
Lab21 is a global provider of state-of-the-art diagnostic products and services, supporting healthcare and environmental markets. Established in 2005 with the vision of providing 21st century diagnostics the Company’s main objective is to protect the health of people and the environment. We believe that ‘prevention is better than cure’ and we aim to provide information that helps to protect from the health problems of tomorrow.

